Amneal Pharmaceuticals Inc [AMRX] stock prices are up 1.68% to $7.85 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The AMRX shares have gain 1.03% over the last week, with a monthly amount drifted -3.09%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Amneal Pharmaceuticals Inc [NASDAQ: AMRX] stock has seen the most recent analyst activity on September 06, 2024, when JP Morgan upgraded its rating to a Neutral but kept the price target unchanged to $9 for it. On March 08, 2021, upgrade upgraded it’s rating to Buy and revised its price target to $6.50 on the stock. Guggenheim upgraded its rating to a Buy but stick to its price target of $5.50 on December 14, 2020. Barclays upgraded its rating to a Overweight and raised its price target to $6 on December 14, 2020. Goldman started tracking with a Sell rating for this stock on July 27, 2020, and assigned it a price target of $4. In a note dated May 12, 2020, Guggenheim upgraded an Neutral rating on this stock.
The stock price of Amneal Pharmaceuticals Inc [AMRX] has been fluctuating between $5.01 and $9.48 over the past year. Currently, Wall Street analysts expect the stock to reach $11.5 within the next 12 months. Amneal Pharmaceuticals Inc [NASDAQ: AMRX] shares were valued at $7.85 at the most recent close of the market. An investor can expect a potential return of 46.5% based on the average AMRX price forecast.
Analyzing the AMRX fundamentals
The Amneal Pharmaceuticals Inc [NASDAQ:AMRX] reported sales of 2.68B for trailing twelve months, representing a surge of 13.29%. Gross Profit Margin for this corporation currently stands at 0.35% with Operating Profit Margin at 0.07%, Pretax Profit Margin comes in at -0.05%, and Net Profit Margin reading is -0.07%. To continue investigating profitability, this company’s Return on Assets is posted at -0.05, Equity is 3.79 and Total Capital is 0.08. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-28.31.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.73 points at the first support level, and at 7.62 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.92, and for the 2nd resistance point, it is at 8.00.
Ratios To Look Out For
It’s worth pointing out that Amneal Pharmaceuticals Inc [NASDAQ:AMRX]’s Current Ratio is 1.38. As well, the Quick Ratio is 0.84, while the Cash Ratio is 0.07. Considering the valuation of this stock, the price to sales ratio is 0.91.
Transactions by insiders
Recent insider trading involved Patel Gautam, Director, that happened on Jan 08 ’25 when 62590.0 shares were sold. Director, Patel Gautam completed a deal on Jan 02 ’25 to sell 17410.0 shares. Meanwhile, Director Gautam J Patel bought 0.32 million shares on Jan 02 ’25.
